Dr. Humza Quadir, MD

Dr. Quadir practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Quadir's NPI, 1194389056, was assigned on April 26, 2019. Dr. Quadir holds Pennsylvania license MD477887.

Dr. Quadir's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Quadir's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Quadir is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quadir practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Quadir's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Quadir is licensed in Pennsylvania.

CMS data shows 338 Medicare services from Dr. Quadir across 5 procedure codes in 2024, for 119 Medicare patients. Medicare paid $24,853 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Dr. Quadir in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quadir's median patient age at 57, with 53% women.

In 2024, Dr. Quadir wrote 60 Medicare Part D claims for 30 patients. 77% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $134 in total drug cost. In 2021, CMS named 71 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Quadir for performance year 2024, reported as part of a group. Dr. Quadir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Quadir from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Hologic Inc paid the most, $15.